SCHEMBL22079889

SCHEMBL22079889

CCNC(=O)c1ccc(NS(=O)(=O)c2ccc(OC(C)(C)CC(C)(C)C(=O)O)cc2)nc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 12/20 0.46
▸ HDAC4 P56524 12/20 0.46
▸ HDAC1 Q13547 12/20 0.46
▸ HDAC7 Q8WUI4 12/20 0.46
▸ HDAC2 Q92769 12/20 0.46
▸ HDAC10 Q969S8 12/20 0.46
▸ HDAC11 Q96DB2 12/20 0.46
▸ HDAC8 Q9BY41 12/20 0.46
▸ HDAC6 Q9UBN7 12/20 0.46
▸ HDAC9 Q9UKV0 12/20 0.46
▸ HDAC5 Q9UQL6 12/20 0.46
▸ SCN9A Q15858 1/20 0.41
▸ SCN3A Q9NY46 1/20 0.40
▸ BRD4 O60885 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22079887 0.89 TDP1 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24257957 0.82 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24257917 0.79 HDAC3 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL22080313 0.79 TDP1 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24257946 0.74 TDP1 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL22105969 0.73 HDAC3 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24257932 0.73 HDAC3 (0.34) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24257969 0.71 TDP1 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL22105939 0.70 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL22079880 0.70 HDAC3 (0.67) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200181223-A1 INSULIN CONJUGATES SANOFI (FR) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181223-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R HDAC3 3410/4885HDAC4 3246/4885HDAC1 2572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback